1. Beland, MD, et al. A pilot study estimating liver fibrosis with ultrasound shear-wave elastography: does the cause of liver disease or location of measurement affect performance? AJR Am J Roentgenol. 2014; 203(3):W267–W273.
2. Jha, RC, et al. LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas. AJR Am J Roentgenol. 2014; 203(1):W48–W69.
3. Khalili, K, et al. Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none? Hepatology. 2011; 54(6):2048–2054.
4. Starr, SP, et al. Cirrhosis: diagnosis, management, and prevention. Am Fam Physician. 2011; 84(12):1353–1359.
5. Vivarelli, M, et al. Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence. World J Gastroenterol. 2011; 17(43):4741–4746.
6. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53(3):397–417.
7. Boll, DT, et al. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. 2009; 29(6):1591–1614.
8. Hanna, RF, et al. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008; 28(3):747–769.